Evidence map›Paper›PMID 34584722›Full record

ArticleClinical case reports2021

Coexisting primary tumors from esophageal cancer and myelodysplastic syndromes: A case report.

Hiroki Imamura, Shigeyuki Tamura, Hideki Hattori, Shinya Kidogami, Yukako Mokutani, Tomoya Kishimoto, Yasuji Hashimoto, Hajime Hirose, Shinichi Yoshioka, Maki Kuwayama and 2 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hiroki ImamuraDepartment of Surgery Yao Municipal Hospital Yao Japan.ORCID https://orcid.org/0000-0001-5363-0661
Shigeyuki TamuraDepartment of Surgery Yao Municipal Hospital Yao Japan.
Hideki HattoriDepartment of Hematology Yao Municipal Hospital Yao Japan.
Shinya KidogamiDepartment of Surgery Yao Municipal Hospital Yao Japan.
Yukako MokutaniDepartment of Surgery Yao Municipal Hospital Yao Japan.
Tomoya KishimotoDepartment of Surgery Yao Municipal Hospital Yao Japan.
Yasuji HashimotoDepartment of Surgery Yao Municipal Hospital Yao Japan.
Hajime HiroseDepartment of Surgery Yao Municipal Hospital Yao Japan.
Shinichi YoshiokaDepartment of Surgery Yao Municipal Hospital Yao Japan.
Maki KuwayamaDepartment of Hematology Yao Municipal Hospital Yao Japan.
Shunji EndoDepartment of Surgery Yao Municipal Hospital Yao Japan.
Yo SasakiDepartment of Surgery Yao Municipal Hospital Yao Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This is the first report of the double primary cancer of esophageal cancer (EC) and myelodysplastic syndromes (MDS) treated without esophagectomy. Previously reported cases of the double cancer mostly describe secondary MDS arising after treatment for EC. The double primary cancer was manageable with close follow-ups for possible recurrence.

Indexed as

double primary canceresophageal cancermyelodysplastic syndromeswithout surgery

Identifiers

PMID34584722
PMCPMC8457412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.